These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 39285446)
21. The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc. Wei Q; Liu Z; Zhu J; Jiang W; Xie H; Feng G; Wang K Front Biosci (Landmark Ed); 2024 Aug; 29(8):296. PubMed ID: 39206900 [TBL] [Abstract][Full Text] [Related]
22. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway. Zhu HE; Yin JY; Chen DX; He S; Chen H Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997 [TBL] [Abstract][Full Text] [Related]
23. N6-methyladenosine-mediated LINC01087 promotes lung adenocarcinoma progression by regulating miR-514a-3p to upregulate centrosome protein 55. Zhang X; Wang DJ; Jia L; Zhang W Kaohsiung J Med Sci; 2024 Sep; 40(9):801-818. PubMed ID: 39023191 [TBL] [Abstract][Full Text] [Related]
25. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma. Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961 [TBL] [Abstract][Full Text] [Related]
26. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546 [TBL] [Abstract][Full Text] [Related]
27. Knockdown of ERO1L attenuates tumor growth, migration and invasion in lung adenocarcinoma through Wnt/β‑catenin pathway. Zhang S; Zhang M; Ma W; Wang L; Yu B Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1910-1923. PubMed ID: 37014092 [TBL] [Abstract][Full Text] [Related]
28. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
29. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma. Ma G; Yang L; Dong J; Zhang L Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009 [TBL] [Abstract][Full Text] [Related]
30. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway. Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698 [TBL] [Abstract][Full Text] [Related]
31. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression. Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989 [TBL] [Abstract][Full Text] [Related]
32. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
33. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis. Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570 [TBL] [Abstract][Full Text] [Related]
34. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway. Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900 [TBL] [Abstract][Full Text] [Related]
35. Ampelopsin induces apoptosis by regulating multiple c-Myc/S-phase kinase-associated protein 2/F-box and WD repeat-containing protein 7/histone deacetylase 2 pathways in human lung adenocarcinoma cells. Chen XM; Xie XB; Zhao Q; Wang F; Bai Y; Yin JQ; Jiang H; Xie XL; Jia Q; Huang G Mol Med Rep; 2015 Jan; 11(1):105-12. PubMed ID: 25333250 [TBL] [Abstract][Full Text] [Related]
36. New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma. Zhao W; Liu Y; Yang Y; Wang L BMC Cancer; 2024 May; 24(1):635. PubMed ID: 38783241 [TBL] [Abstract][Full Text] [Related]
37. NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma Chen L; Yang D; Huang F; Xu W; Luo X; Mei L; He Y Comb Chem High Throughput Screen; 2024; 27(2):203-213. PubMed ID: 37114782 [TBL] [Abstract][Full Text] [Related]
38. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma. Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818 [TBL] [Abstract][Full Text] [Related]
39. Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1. Lai Q; Wan Y; Zhang Y; Huang Y; Tang Q; Chen M; Li Q; Ma K; Xiao P; Luo C; Zhuang X Mol Carcinog; 2024 Jul; 63(7):1260-1274. PubMed ID: 38607240 [TBL] [Abstract][Full Text] [Related]
40. lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize Peng W; Jiang J; Fu J; Duan H; Wang J; Duan C Epigenomics; 2023 Apr; 15(7):417-434. PubMed ID: 37309595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]